BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6577209)

  • 21. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
    Nesbit M; Chard R; Evans A; Karon M; Hammond GD
    Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Remission induction with vincristine and prednisolone alone in adult acute lymphocytic leukemia].
    Saito K; Kajitani H; Okuyama A; Osato M; Hara M; Watanabe K; Dobashi Y; Yamazaki T; Hamaguchi H; Sakamaki H
    Rinsho Ketsueki; 1984 Sep; 25(9):1388-93. PubMed ID: 6596449
    [No Abstract]   [Full Text] [Related]  

  • 25. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG; Reaman GH; Wesley R
    Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with L-asparaginase of renal and testicular involvement in acute lymphoblastic leukemia in children (author's transl)].
    Armata J; Cyklis R; Legutko L
    Acta Paediatr Belg; 1974; 28(1):49-57. PubMed ID: 4526297
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
    Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
    Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Concepts in therapy of the first relapse in acute lymphoblastic leukaemia: experience with 28 children (author's transl)].
    Marsmann G; Winkler K; Gaedicke G; Landbeck G
    Klin Padiatr; 1977 Jan; 189(8):41-3. PubMed ID: 264987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
    Morland BJ; Shaw PJ
    Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow].
    Cyklis R; Armata J; Legutko L
    Acta Haematol Pol; 1974; 5(3):201-6. PubMed ID: 4528224
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Repeated treatment with L-asparaginase of acute lymphoblastic leukemia in children].
    Zajaczkowski J; Depowska T; Legutko L; Armata J
    Pol Tyg Lek; 1974 Aug; 29(32):1381-3. PubMed ID: 4527522
    [No Abstract]   [Full Text] [Related]  

  • 34. [Attempt of treatment of acute lymphoblastic leukemia by L-asparaginase].
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; De Vassal F; Jasmin C; Rosenfeld C
    Presse Med (1893); 1969 Mar; 77(13):461-3. PubMed ID: 5255425
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intensive chemotherapy of acute lymphoblastic leukemia in childhood: evaluation of our experience].
    Tontoli N; Correra A; Saviano P; Vetrella A; De Masi RV; Florino G; Lagonigro F
    Pediatria (Napoli); 1981 Dec; 89(4):805-13. PubMed ID: 6955759
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME; Ertel I; Hammond GD
    Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Remission induction and maintenance with multi-drug regimen (modified LSA2L2) for acute lymphoblastic leukemia in children].
    Shitara T; Kuribayashi T; Oshima Y; Hiraishi Y
    Rinsho Ketsueki; 1983 Nov; 24(11):1479-83. PubMed ID: 6584649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.